J9293 Mitoxantrone hydrochl / 5 milligrams
Also known as: mitoxantrone, Novantrone
Injection of mitoxantrone hydrochloride, 5 milligram. A topoisomerase II inhibitor anthracenedione used for leukemia and multiple sclerosis.
In Plain Language
leukemia cancer injection; multiple sclerosis treatment
Clinical Context
Used for secondary progressive multiple sclerosis and acute myeloid leukemia. Provides both antimicrobial and antileukemic activities.
RVU Information
CPT J9293 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9293?
CPT J9293 (Mitoxantrone hydrochl / 5 milligrams) is a J Codes (Drugs) code. Injection of mitoxantrone hydrochloride, 5 milligram. A topoisomerase II inhibitor anthracenedione used for leukemia and multiple sclerosis.
How is J9293 administered?
CPT J9293 is administered by a healthcare provider, typically via injection or infusion. Used for secondary progressive multiple sclerosis and acute myeloid leukemia. Provides both antimicrobial and antileukemic activities. It is used by Oncology, Neurology, Internal Medicine.
When is CPT J9293 used?
Used for secondary progressive multiple sclerosis and acute myeloid leukemia. Provides both antimicrobial and antileukemic activities.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.